NUVA logo

NuVasive (NUVA) Selling, General & Administrative Expenses

Annual SG&A

$634.10 M
+$24.01 M+3.94%

31 December 2022

NUVA Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$163.86 M
-$12.33 M-7.00%

30 June 2023

NUVA Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

$325.72 M
+$28.45 M+9.57%

30 June 2023

NUVA TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NUVA Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+3.9%+2.0%-46.6%
5 y5 years+3.8%+2.2%-46.7%

NUVA Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-7.0%-50.1%

NuVasive Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
June 2023
-
$163.86 M(-7.0%)
$653.17 M(+0.5%)
Mar 2023
-
$176.19 M(+10.7%)
$650.01 M(+2.5%)
Dec 2022
$634.10 M(+3.9%)
$159.11 M(+3.3%)
$634.10 M(-0.2%)
Sept 2022
-
$154.00 M(-4.2%)
$635.66 M(+1.3%)
June 2022
-
$160.70 M(+0.3%)
$627.71 M(+0.5%)
Mar 2022
-
$160.28 M(-0.2%)
$624.41 M(+2.3%)
Dec 2021
$610.09 M(+11.5%)
$160.68 M(+10.0%)
$610.09 M(+2.8%)
Sept 2021
-
$146.06 M(-7.2%)
$593.67 M(-0.0%)
June 2021
-
$157.40 M(+7.8%)
$593.87 M(+5.5%)
Mar 2021
-
$145.95 M(+1.2%)
$562.92 M(+2.9%)
Dec 2020
$547.20 M(-10.5%)
$144.26 M(-1.4%)
$547.20 M(-2.9%)
Sept 2020
-
$146.26 M(+15.7%)
$563.30 M(-1.2%)
June 2020
-
$126.44 M(-2.9%)
$569.93 M(-4.4%)
Mar 2020
-
$130.23 M(-18.8%)
$596.34 M(-2.4%)
Dec 2019
$611.18 M(+6.1%)
$160.37 M(+4.9%)
$611.18 M(+3.1%)
Sept 2019
-
$152.89 M(+0.0%)
$593.02 M(+2.0%)
June 2019
-
$152.85 M(+5.4%)
$581.34 M(+1.3%)
Mar 2019
-
$145.08 M(+2.0%)
$574.15 M(-0.3%)
Dec 2018
$575.84 M(+6.7%)
$142.20 M(+0.7%)
$575.84 M(+1.4%)
Sept 2018
-
$141.21 M(-3.1%)
$568.16 M(+2.8%)
June 2018
-
$145.66 M(-0.8%)
$552.60 M(+1.2%)
Mar 2018
-
$146.77 M(+9.1%)
$545.90 M(+1.2%)
Dec 2017
$539.51 M(+1.1%)
$134.52 M(+7.1%)
$539.51 M(-1.4%)
Sept 2017
-
$125.65 M(-9.6%)
$547.37 M(-1.1%)
June 2017
-
$138.97 M(-1.0%)
$553.61 M(+0.8%)
Mar 2017
-
$140.37 M(-1.4%)
$549.13 M(+2.9%)
Dec 2016
$533.60 M(+16.7%)
$142.39 M(+8.0%)
$533.60 M(+4.6%)
Sept 2016
-
$131.89 M(-1.9%)
$510.05 M(+4.4%)
June 2016
-
$134.49 M(+7.7%)
$488.71 M(+4.2%)
Mar 2016
-
$124.84 M(+5.1%)
$468.91 M(+1.9%)
Dec 2015
$457.28 M(+0.1%)
$118.84 M(+7.5%)
$460.17 M(+2.4%)
Sept 2015
-
$110.55 M(-3.6%)
$449.21 M(-0.7%)
June 2015
-
$114.68 M(-1.2%)
$452.40 M(-0.5%)
Mar 2015
-
$116.10 M(+7.6%)
$454.69 M(-0.4%)
Dec 2014
$456.70 M(+8.7%)
$107.88 M(-5.2%)
$456.70 M(-1.3%)
Sept 2014
-
$113.75 M(-2.8%)
$462.64 M(+2.6%)
June 2014
-
$116.97 M(-1.0%)
$450.98 M(+2.9%)
Mar 2014
-
$118.10 M(+3.8%)
$438.28 M(+4.3%)
Dec 2013
$420.06 M
$113.82 M(+11.5%)
$420.06 M(+4.0%)
Sept 2013
-
$102.08 M(-2.1%)
$403.96 M(+3.8%)
DateAnnualQuarterlyTTM
June 2013
-
$104.27 M(+4.4%)
$389.28 M(+3.1%)
Mar 2013
-
$99.89 M(+2.2%)
$377.62 M(+1.4%)
Dec 2012
$372.42 M(+6.7%)
$97.71 M(+11.8%)
$372.42 M(+0.7%)
Sept 2012
-
$87.41 M(-5.6%)
$369.73 M(+0.5%)
June 2012
-
$92.61 M(-2.2%)
$367.80 M(+2.3%)
Mar 2012
-
$94.68 M(-0.4%)
$359.51 M(+3.0%)
Dec 2011
$349.05 M(+10.9%)
$95.03 M(+11.2%)
$349.05 M(+3.1%)
Sept 2011
-
$85.48 M(+1.4%)
$338.60 M(+2.3%)
June 2011
-
$84.32 M(+0.1%)
$330.83 M(+2.0%)
Mar 2011
-
$84.22 M(-0.4%)
$324.23 M(+3.0%)
Dec 2010
$314.68 M(+23.4%)
$84.57 M(+8.8%)
$314.68 M(+4.0%)
Sept 2010
-
$77.72 M(-0.0%)
$302.58 M(+5.6%)
June 2010
-
$77.73 M(+4.1%)
$286.58 M(+6.5%)
Mar 2010
-
$74.66 M(+3.0%)
$269.13 M(+5.5%)
Dec 2009
$255.00 M(+34.8%)
$72.48 M(+17.4%)
$255.00 M(+8.2%)
Sept 2009
-
$61.72 M(+2.4%)
$235.67 M(+3.1%)
June 2009
-
$60.27 M(-0.4%)
$228.51 M(+8.6%)
Mar 2009
-
$60.53 M(+13.9%)
$210.33 M(+11.2%)
Dec 2008
$189.13 M(+58.2%)
$53.15 M(-2.6%)
$189.12 M(+10.9%)
Sept 2008
-
$54.56 M(+29.6%)
$170.54 M(+17.7%)
June 2008
-
$42.10 M(+7.1%)
$144.93 M(+10.8%)
Mar 2008
-
$39.32 M(+13.7%)
$130.86 M(+9.1%)
Dec 2007
$119.58 M(+25.3%)
$34.57 M(+19.4%)
$119.99 M(+7.8%)
Sept 2007
-
$28.95 M(+3.3%)
$111.29 M(+3.2%)
June 2007
-
$28.03 M(-1.5%)
$107.89 M(-5.1%)
Mar 2007
-
$28.45 M(+10.0%)
$113.63 M(+6.9%)
Dec 2006
$95.43 M(+67.4%)
$25.87 M(+1.3%)
$106.31 M(+9.4%)
Sept 2006
-
$25.54 M(-24.4%)
$97.21 M(+12.6%)
June 2006
-
$33.77 M(+59.8%)
$86.36 M(+30.5%)
Mar 2006
-
$21.13 M(+26.0%)
$66.17 M(+16.0%)
Dec 2005
$57.02 M(+67.0%)
$16.77 M(+14.1%)
$57.02 M(+14.6%)
Sept 2005
-
$14.69 M(+8.2%)
$49.76 M(+14.5%)
June 2005
-
$13.58 M(+13.3%)
$43.47 M(+11.3%)
Mar 2005
-
$11.98 M(+26.0%)
$39.06 M(+12.7%)
Dec 2004
$34.14 M(+74.8%)
$9.51 M(+13.2%)
$34.64 M(+37.8%)
Sept 2004
-
$8.40 M(-8.4%)
$25.14 M(+50.2%)
June 2004
-
$9.17 M(+21.1%)
$16.73 M(+121.1%)
Mar 2004
-
$7.57 M
$7.57 M
Dec 2003
$19.54 M(+24.4%)
-
-
Dec 2002
$15.71 M(+384.6%)
-
-
Dec 2000
$3.24 M
-
-

FAQ

  • What is NuVasive annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for NuVasive?
  • What is NuVasive quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for NuVasive?
  • What is NuVasive TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for NuVasive?

What is NuVasive annual selling, general & administrative expenses?

The current annual SG&A of NUVA is $634.10 M

What is the all time high annual SG&A for NuVasive?

NuVasive all-time high annual selling, general & administrative expenses is $634.10 M

What is NuVasive quarterly selling, general & administrative expenses?

The current quarterly SG&A of NUVA is $163.86 M

What is the all time high quarterly SG&A for NuVasive?

NuVasive all-time high quarterly selling, general & administrative expenses is $176.19 M

What is NuVasive TTM selling, general & administrative expenses?

The current TTM SG&A of NUVA is $325.72 M

What is the all time high TTM SG&A for NuVasive?

NuVasive all-time high TTM selling, general & administrative expenses is $653.17 M